Literature DB >> 17637446

Generalized Dowling-Degos disease.

Yu-Hung Wu1, Yang-Chih Lin.   

Abstract

BACKGROUND: Dowling-Degos disease (DDD) is a rare inherited disease characterized by reticular hyperpigmentation on flexor surfaces.
OBJECTIVE: We sought to describe several cases of generalized DDD, a presentation that resemble dyschromatosis universalis hereditaria.
METHODS: The clinical manifestations, histopathologic, and genetic studies of a family with autosomal dominant inheritance were analyzed.
RESULTS: The father and his sister had reticular hyperpigmentation on flexor surfaces, whereas the daughter and son had generalized hyperpigmentation with numerous hypopigmented or erythematous macules and papules on the trunk and limbs. Skin biopsy specimens from both types of lesions all had typical features of DDD. Biopsy specimens from axillary skin had features of Galli-Galli disease, an acantholytic form. There were no mutations of the double-stranded RNA-specific adenosine deaminase or keratin 5 genes. LIMITATION: Generalizations cannot be drawn from genetic study of only one family.
CONCLUSION: DDD can present with generalized hyperpigmentation and hypopigmented papules.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17637446     DOI: 10.1016/j.jaad.2006.12.023

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  10 in total

1.  Generalized dowling-degos disease: case reports.

Authors:  Jade Wititsuwannakul; Nopadon Noppakun
Journal:  Ann Dermatol       Date:  2013-08-13       Impact factor: 1.444

2.  A case of dowling-degos disease on the vulva.

Authors:  Ho Song Kang; Jae Hur; Jung Woo Lee; Dae Heon Oh; Kwang Yeoll Yeo; Joung Soo Kim; Hee Joon Yu
Journal:  Ann Dermatol       Date:  2011-05-27       Impact factor: 1.444

3.  [Galli-Galli disease. Clinical and histopathological investigation using a case series of 18 patients].

Authors:  S Hanneken; A Rütten; S Eigelshoven; M Braun-Falco; S M Pasternack; T Ruzicka; M M Nöthen; R C Betz; R Kruse
Journal:  Hautarzt       Date:  2011-11       Impact factor: 0.751

4.  Mutations in POFUT1, encoding protein O-fucosyltransferase 1, cause generalized Dowling-Degos disease.

Authors:  Ming Li; Ruhong Cheng; Jianying Liang; Heng Yan; Hui Zhang; Lijia Yang; Chengrang Li; Qingqing Jiao; Zhiyong Lu; Jianhui He; Jin Ji; Zhu Shen; Chunqi Li; Fei Hao; Hong Yu; Zhirong Yao
Journal:  Am J Hum Genet       Date:  2013-05-16       Impact factor: 11.025

5.  Acropigmentation of Kitamura with immigration delay disease: A rare entity.

Authors:  Sumir Kumar; Bharat Bhushan Mahajan; Nidhi Kamra; Pritish A Bhoyar
Journal:  Indian Dermatol Online J       Date:  2015 May-Jun

6.  A case of dyschromatosis universalis hereditaria with adermatoglyphia: A rare association.

Authors:  Sumir Kumar; Pritish Bhoyar; Bharat Bhushan Mahajan
Journal:  Indian Dermatol Online J       Date:  2015 Mar-Apr

7.  Atypical cases of Dowling-Degos disease.

Authors:  Kikkeri Narayanshetty Naveen; Sharatchandra B Athaniker; Spandana P Hegde; Rahul Shetty; Hanumanthayya Radha; Sadashivappa Sangam Parinitha
Journal:  Indian Dermatol Online J       Date:  2016 Mar-Apr

8.  A case of reticulate acropigmentation of kitamura: dowling degos disease overlap with unusual clinical manifestations.

Authors:  Biju Vasudevan; Rajesh Verma; Sonia Badwal; Vijendran Pragasam; Nikhil Moorchung; Ambresh Badad
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494

9.  The First Report of KRT5 Mutation Underlying Acantholytic Dowling-Degos Disease with Mottled Hypopigmentation in an Indian Family.

Authors:  Shyam Verma; Sandra M Pasternack; Arno Rütten; Thomas Ruzicka; Regina C Betz; Sandra Hanneken
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

10.  Dowling-Degos disease with reticulate acropigmentation of Kitamura: Extended spectrum of a single entity.

Authors:  Shyam Govind Rathoriya; Sumit S L Soni; Dinesh Asati
Journal:  Indian Dermatol Online J       Date:  2016 Jan-Feb
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.